jRCT2031240458进行中（未招募）不适用
A Phase 1,randomized,placebo-controlled,double-blind, single and multiple dose study of M136101 in healthy subjects.
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 24
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized Controlled Trial
- 干预模型
- Parallel Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Double Blind
入排标准
- 年龄范围
- 18age old over 至 45age old not（—）
- 性别
- Male
入选标准
- •Males who are 18 to 44 years of age at the time of informed consent.
排除标准
- •(1)individuals with a history of or concomitant diseases that are considered inappropriate for participation in a clinical trial, such as serious cardiac, hepatic, pulmonary, renal, or hematological diseases.
- •(2)Individuals with abnormal findings at the administration site.
- •(3)Individuals who are judged to be unsuitable as subject by the principal (sub) investigator.
结局指标
主要结局
-
Tolerability, Safety, PK
次要结局
未报告次要终点
研究者
相似试验
已完成
1 期
Single Ascending Dose Study of M529101 in Healthy SubjectsJPRN-jRCT2031210455ishiura Tomoyuki32
招募中
2 期
M201-ASymptomatic Paroxysmal atrial fibrillationJPRN-jRCT2031190069Kumagai Yuji42
招募中
2 期
Effecting the combination of memantine and methylphenidate in children affected by attention deficit hyperactivity disorderIRCT20100520003979N8Ahvaz University of Medical Sciences69
已完成
不适用
The effects of a single oral therapeutic dose of Moxifloxacin on the QT/QTc interval and pharmacokinetics of healthy Japanese male volunteers. - multicenter, digital 12-lead Holter ECG trialHealthy maleJPRN-UMIN000005924Medical Co. LTA Clinical Pharmacology Center64
招募中
1 期
An ascending single and multiple dose study of the safety, tolerability, pharmacokinetics and anti-tumour activity of once-daily oral treatment with EO1001 in patients with advanced cancer.ACTRN12620000583943Senz Oncology Pty Ltd50